UBS lowered the firm’s price target on Tronox to $18 from $19 and keeps a Neutral rating on the shares. After a review of price and volume trends and updates on chemical spreads and prices, the firm’s Q2 estimates are reduced about 2% in aggregate across its North American Chemicals coverage, the analyst tells investors in an earnings preview note for the group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TROX:
Questions or Comments about the article? Write to editor@tipranks.com